WASHINGTON--(BUSINESS WIRE)--Counsyl, a DNA testing and genetic counseling service, today announced its upcoming presentation of, “Not Your Mother’s Pregnancy: Guide to Genetic Testing for the Busy OB/GYN Provider” at The American College of Obstetricians (ACOG) 2016 Annual Clinical and Scientific Meeting. The presentation will address best practices for integrating genetic testing into clinical practice.
Shivani Nazareth, Director of Women’s Health at Counsyl, will discuss some of the recent advances in genetic testing and how to discern what’s important amidst rapidly changing technologies. Dr. Mareca Pallister, a full-time obstetrician in Colorado, will present her personal experience in offering genetic testing more broadly into her own clinical practice, in light of evolving guidelines for prenatal screening and the growing needs of patients.
The presentation is scheduled for Monday, May 16, 2016 at 5:45 PM (ET) at the Walter E. Washington Convention Center (Room 206 ABC) in Washington, D.C.
The ACOG 2016 Annual Clinical and Scientific Meeting is dedicated to delivering the latest scientific information to benefit OB/GYN providers and their patients.
About Counsyl
Counsyl is a health technology company that offers DNA testing for diseases that can impact men, women and their children. The Counsyl philosophy is simple: screen for diseases where advanced knowledge makes a difference in health outcomes, whether it’s changing a behavior, pursuing preventative measures, or simply preparing for what lies ahead.
The Counsyl team includes an accomplished group of problem-solvers — top engineers, scientists, and designers — who are taking the lead on building the modern clinical laboratory. Scientific rigor, custom robotics, and software are at the heart of every Counsyl product, resulting in better, faster and more affordable screens that are broadly accessible. Beyond the laboratory, Counsyl offers doctors and patients a technology platform for results delivery in real time, with on-demand access to board-certified genetic counselors.
Counsyl has screened more than 500,000 patients and served more than 6,000 health care professionals in its CLIA-certified, CAP-accredited and NYS CLEP-permitted clinical laboratory. The company has raised a total of $102 million and is privately backed by RSTP, Goldman Sachs Asset Management, Founders Fund, Felicis Ventures, David Drummond, and other high profile investors.
